We used the MYH9-overexpression vector (MYH9 OE) to identify the phenotype of U87 and LN229 cells after functional recovery of MYH9, and the results also suggested that MYH9 promoted proliferation, invasion, migration, and chemotherapy resistance in glioma cells (Supplemental Fig. 2). Here, MYH9 is linked to central nervous system cancer.